{ "items": [ "\n\n
\n \n\n \n \n \n \n CVM\n \n \n \n \n OCDEM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n4 April 2017
\n \n \n \nAn exciting new chapter in NHS medical research in Oxford began at the start of April, with the \u00a3113.7m renewal of the NIHR Oxford Biomedical Research Centre (BRC).
\n \n\n \n \n\n \n\n \n \n \n \n CVM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n15 March 2017
\n \n \n \nAn Oxfordshire coroner recently announced that George Michael died of natural causes. The post-mortem examination revealed that the singer suffered from a number of health problems, including dilated cardiomyopathy.
\n \n\n \n \n\n \n\n \n \n \n \n CVM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n15 March 2017
\n \n \n \nWould you want to know if you were at a higher risk of getting dementia later in life? Would you want to know that you could die under general anaesthesia, or might die suddenly of heart failure? Would you want to know if you had a higher-than-normal chance of getting cancer? You could learn these things by looking at your genome. But would you want to be faced with the answers?
\n \n\n \n \n\n \n\n \n \n \n \n CVM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n21 February 2017
\n \n \n \nOxford University and Evotec\u2019s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards.
\n \n\n \n \n\n \n\n \n \n \n \n OCDEM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n30 January 2017
\n \n \n \nInternational research company Novo Nordisk is investing \u00a3115 million in a new research centre at the University of Oxford, as part of a new type 2 diabetes research collaboration with the University.
\n \n\n \n \n\n \n\n \n \n \n \n CVM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n27 January 2017
\n \n \n \nResearchers from the University of Oxford are collaborating with the Japanese pharmaceutical company, SBI Pharmaceuticals, to minimise deterioration of heart function outcomes after cardiac surgery.
\n \n\n \n \n\n \n\n \n \n \n \n NDCLS\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n17 November 2016
\n \n \n \nOne of the great mysteries in biology is how the many different cell types that make up our bodies are derived from a single cell and from one DNA sequence, or genome.
\n \n\n \n \n\n \n\n \n \n \n \n OCDEM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n29 September 2016
\n \n \n \nNew research finds genetic differences that help to explain why some babies are born bigger or smaller than others. The research, led by the University of Oxford, also reveals how genetic differences provide an important link between an individual\u2019s early growth and their chances of developing conditions such as type 2 diabetes or heart disease in later life.
\n \n\n \n \n\n \n\n \n \n \n \n CVM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n23 September 2016
\n \n \n \nThe largest NHS-based centre to identify genetic causes of heart disease has welcomed its 10,000th patient. Founded by Oxford University and NHS staff, the Oxford Medical Genetics Laboratory at the Churchill Hospital began its cardiac genetic testing service in 2003 and was the first accredited NHS diagnostic genetic testing service for inherited cardiac conditions (ICC) in the UK.
\n \n\n \n \n\n \n\n \n \n \n \n OCDEM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 August 2016
\n \n \n \nRDM researchers have uncovered new genetic evidence of how the benefits of the world\u2019s most commonly used Type 2 diabetes drug may vary between individuals.
\n \n\n \n \n\n \n\n \n \n \n \n CVM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 August 2016
\n \n \n \nA groundbreaking study, led by experts from the University of Oxford and Royal Brompton Hospital, has discovered better methods to interpret the significance of gene mutations in patients who are tested for genetic conditions. The findings mean that, in future, more diagnoses could be made through genetic testing.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 July 2016
\n \n \n \nProf Mark McCarthy and a team of over 300 scientists have published new findings into the genetic causes of type 2 diabetes.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n14 June 2016
\n \n \n \nIt\u2019s World Blood Donor Day and many people will have been inspired to give a pint to help others. But what actually happens to your blood after you\u2019ve donated it and are recovering with a couple of biscuits?
\n \n\n \n \n\n \n\n \n \n \n \n CCRF\n \n \n \n \n CVM\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n14 June 2016
\n \n \n \nBreastfeeding premature babies improves long-term heart structure and function, Dr Adam Lewandowski and colleagues in the Cardiovascular Clinical Research Facility have found.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 June 2016
\n \n \n \nProfessors Irv Weissman and Ravi Majeti at Stanford University and Professor Paresh Vyas at the MRC Molecular Haematology Unit, are working on an antibody from the Stanford investigators that enables the immune system to detect and kill cancer cells.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n5 May 2016
\n \n \n \nWhen is the best time to start taking statins? New research from Prof Barbara Casadei shows that short term use of statins, just before and after heart surgery, may not be as beneficial as first thought. The team\u2019s new work in 2,000 people undergoing heart surgery showed that short term statin use doesn\u2019t decrease the risk of heart damage or atrial fibrillation (a common side effect after surgery), and can in fact increase the risk of kidney damage.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n9 February 2016
\n \n \n \nResearch by Prof Andrew Wilkie and Prof Anne Goriely, published in PNAS, has identified the origins of some severe disease-causing mutations within the testicles of normal men. Particular mutations in the FGFR2 gene and a few other disease genes enable the mutated spermatogonia to produce not just sperm but extra copies of themselves, reproducing and spreading faster than the surrounding normal spermatogonia. This tumour-like growth means that over time, a greater proportion of sperm being produced carry disease-causing mutations, increasing the risk of fathering a child with a serious condition.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 February 2016
\n \n \n \nDr Luca Biasiolli, based in OCMR, is studying whether a new type of MRI scan offers a more accurate and easier way to identify the potentially dangerous plaques that cause stroke. Her research is supported by the British Heart Foundation. A stroke happens when the blood supply to part of your brain is cut off. Most occur as a consequence of plaque \u2013 a condition called atherosclerosis \u2013 building up in arteries in the neck. If a piece of this plaque breaks off, it can lead to a clot forming in the brain and cause a stroke.
\n \n\n \n \n\n \n\n \n \n \n \n Department\n \n \n \n \n IMD\n \n \n \n \n MRC HIU\n \n \n \n \n MRC TIDU\n \n \n \n \n MRC WIMM\n \n \n \n \n NDCLS\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n26 January 2016
\n \n \n \nOxford, UK: 23 May, 2018: Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a \u00a36.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and Oxford University. Additionally, Borealis Managing Partner Phil Ferneau and Oxford Investment Consultants\u2019 Partner James Mallinson join Orbit\u2019s Board of Directors.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n4 January 2016
\n \n \n \nBlood pressure-lowering drugs should be offered to all individuals at high risk of having a heart attack or stroke regardless of their blood pressure at the start of treatment, according to the largest meta-analysis conducted to date involving over 600,000 people, published in The Lancet.
\n \n\n \n \n